A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic)

Por Fallu, Angelo, Dabouz, Farida, Furtado, Melissa, Anand, Leena, Katzman, Martin A.
Publicado no Ther Adv Psychopharmacol (2016)